21 U.S.C. § 360fff–4 — Guidance; other provisions
submitted 88 years ago by Pub. L. 113-195 to r/title-21-FOOD-AND-DRUGS · 508 words · no verdicts yet
The FDA must write and finalize guidance explaining how sunscreen makers should follow this law. This part doesn't change how currently marketed sunscreens are treated, or the FDA's other drug-safety powers. Certain review deadlines stop applying to new requests filed more than 6 years after November 26, 2014.
Not later than 1 year after November 26, 2014, the Secretary* shall issue draft guidance on the implementation of, and compliance with, the requirements with respect to sunscreen* under this part, including guidance on—
the format and content of information submitted by a sponsor* in support of a request under section 360fff–1 of this title or a pending request*;
the data required to meet the safety and efficacy standard for determining whether a nonprescription* sunscreen active ingredient* or combination of nonprescription sunscreen active ingredients is GRASE* and is not misbranded;
the process by which a request under section 360fff–1 of this title or a pending request is withdrawn; and
the process by which the Secretary will carry out section 360fff–3(c) of this title, including with respect to how the Secretary will address the total number of requests received under section 360fff–1 of this title and pending requests.
The Secretary shall finalize the guidance described in subparagraph (A) not later than 2 years after November 26, 2014.
Chapter 35 of title 44 shall not apply to collections of information made for purposes of guidance under this subsection.
Irrespective of whether final guidance under paragraph (1) has been issued—
persons may, beginning on November 26, 2014, make submissions under this part; and
the Secretary shall review and act upon such submissions in accordance with this part.
Nothing in this part shall be construed to affect the marketing of sunscreens that are marketed in interstate commerce* on or before November 26, 2014, except as otherwise provided in this part.
Nothing in this part shall be construed to alter the authority of the Secretary with respect to prohibiting the marketing of a sunscreen that is not safe and effective or is misbranded, or with respect to imposing restrictions on the marketing of a sunscreen to ensure safety and effectiveness, except as otherwise provided in this part, including section 360fff–3(e) of this title.
Except as otherwise provided in section 360fff–6 of this title, nothing in this part shall be construed to affect the authority of the Secretary under this chapter or the Public Health Service Act (42 U.S.C. 201 et seq.) with respect to a drug* other than a nonprescription sunscreen.
Nothing in this part shall affect the marketing of a drug approved under section 355 of this title or section 351 of the Public Health Service Act [42 U.S.C. 262].
The timelines for the processes and procedures under paragraphs (1), (2), (5), and (6) of section 360fff–3(a) of this title shall not apply to any requests submitted to the Secretary under section 360fff–1 of this title after the date that is 6 years after November 26, 2014.
Source credit: (June 25, 1938, ch. 675, § 586D, as added Pub. L. 113–195, § 2(a), Nov. 26, 2014, 128 Stat. 2044.)
- 1938Enacted · Pub. L. 113-195 · 128 Stat. 2044
A history note hasn’t been published yet. The record shows enactment by Pub. L. 113-195 on 1938-06-25.
all 0 arguments · sorted by: best
no arguments yet — make the first case